Eli Lilly Looks To Enter Oncology Market With New Partner

Jan. 13, 2005
After signing an elaborate research partnership in April with France's Sanofi SA to codevelop and comarket the oncology drug oxaliplatin in the U.S., Eli Lilly is eager to magnify its presence in the oncology market, Garry Nicholson, director of the ...

After signing an elaborate research partnership in April with France's Sanofi SA to codevelop and comarket the oncology drug oxaliplatin in the U.S., Eli Lilly is eager to magnify its presence in the oncology market, Garry Nicholson, director of the company's U.S. oncology division says. Nicholson is optimistic about approval from the U.S. Food and Drug Administration (FDA) for the drug, which is expected to be submitted to the FDA in September or October. Eli Lilly's agreement with Sanofi will entail that both companies jointly submit, register, develop, and market oxaliplatin in the U.S. The agreement helps Sanofi to expand its presence in the U.S. and is a step for Lilly to enter the oncology market, which records 140,000 new cases of colorectal cancer diagnosed each year, according to data from the American Cancer Society. Oxaliplatin is a platinum-based treatment for all forms of colorectal cancer, and is developed and marketed by Sanofi in France and other European countries for first-line treatment of colorectal cancer. Sanofi acquired the license to develop oxaliplatin from a Swiss pharmaceutical company in 1994.

Popular Sponsored Recommendations

Decarbonization Navigator: A Toolkit for Organizations

Sept. 28, 2023
The increasing urgency of addressing climate change along with stakeholder pressures are driving the need for organizations to prioritize decarbonization. Discover how to start...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

The Benefits of Continuous Thermal Monitoring

Oct. 17, 2023
Read this eBook to learn more about collecting and using data intelligently to improve performance.

Process Mining For Dummies

Nov. 19, 2023
Here it is. Everything you need to know about process mining in a single book, written in the easy-to-understand, hard-to-forget style that ‘For Dummies’ manages so effortlessly...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!